| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024046 |
| Receipt No. | R000027691 |
| Scientific Title | Development of personalized medicine for depressed patients by elucidating the pathogeneses of depression considering involvement of nutrition, lifestyle and inflammation |
| Date of disclosure of the study information | 2016/09/14 |
| Last modified on | 2019/03/20 (Ver. 4) |
| Basic information | ||
| Public title | Development of personalized medicine for depressed patients by elucidating the pathogeneses of depression considering involvement of nutrition, lifestyle and inflammation | |
| Acronym | Development of personalized medicine for depression | |
| Scientific Title | Development of personalized medicine for depressed patients by elucidating the pathogeneses of depression considering involvement of nutrition, lifestyle and inflammation | |
| Scientific Title:Acronym | Development of personalized medicine for depression | |
| Region |
|
|
| Condition | |||
| Condition | Depression, Postpartum depression | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | Objectives are: 1) to reveal the pathogeneses for depression by analyzing information and specimens collected by Tohoku Medical Megabank Project (including the population-based adult cohort study, and the birth and three-generation cohort study), considering profiles of subjects regarding nutrition, lifestyle and inflammation, 2) to reveal the pathogeneses of postpartum depression by conducting add-on follow-up studies of the mothers enrolled to the three-generation cohort study, 3) to develop technologies for objective evaluation of depression, and for predictions of onset and prognosis of depression, based on the above findings. |
| Basic objectives2 | Others |
| Basic objectives -Others | To clarify the pathogeneses of depression and postpartum depression |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | [Postpartum depression assessments]
Edinburgh Postnatal Depression Scale: EPDS [Assessment of diagnosis and mental state] Semi-structured interview for evaluating mental state [Plasma] 1. Concentrations of protein, lipid, metabolite, etc. 2. Concentrations of inflammatory substances (cytokine, chemokine, complement components, High-sensitive C-reactive protein etc.) 3. Concentrations of hormones (Estradiol, progesterone, testosterone, cortisol, etc.) [Fecal specimens] Intestinal flora (bifidobacteria, lactic acid bacteria, etc.) [Daily life] 1. Physical activities and movement in daily life 2. Daylight hours 3. Sleeping pattern 4. Heart rate |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | The subjects consists of:
1. Women who have enrolled to the third generation cohort of Tohoku Medical Megabank Organization (approved by the Ethics Committee of Tohoku University Graduate School of Medicine: 2016-4-013, 2014-4-015), and who experienced delivery before April of 2016, and who have become pregnant between April, 2017 and April, 2021. 2. Women who experienced postpartum depression after the previous delivery are prioritized. 3. People who are 20 years of age or more. 4. People who provide written informed consent. |
|||
| Key exclusion criteria | 1. Patients affected by infectious diseases, malignant tumor, severe diabetes, or other severe systemic diseases.
2. Patients who are considered to be inappropriate to participate to this study, by a physician who is in charge of this project or who is involved in the project. |
|||
| Target sample size | 720 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Tohoku University Graduate school of Medicine | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 980-8575 | ||||||
| Address | 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8573, Japan | ||||||
| TEL | 81-22-717-7262 | ||||||
| htomita@med.tohoku.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Tohoku University Graduate school of Medicine | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 980-8575 | ||||||
| Address | 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8573, Japan | ||||||
| TEL | 81-22-717-7897 | ||||||
| Homepage URL | |||||||
| jimu_dpsy@irides-dpsy.med.tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku University Graduate school of Medicine
Department of Psychiatry |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | Government offices of other countries |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | nstitutional Review Board, Graduate school of Medicine, Tohoku University |
| Address | 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8573, Japan |
| Tel | 81-22-717-8007 |
| med-kenkyo@grp.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.mentalhealth.megabank.tohoku.ac.jp/index.html |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027691 |